James McKerrow, MD, Ph.D., dean of the Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego, has long studied neglected tropical diseases—chronic […]
A personalized tumor cell vaccine strategy targeting Myc oncogenes combined with checkpoint therapy creates an effective immune response that bypasses antigen selection and immune privilege, according […]
(HealthDay)—Women experience an accelerated increase in visceral adipose tissue (VAT) starting two years before menopause, which is associated with a greater risk for subclinical atherosclerosis in […]